ADIPOQ and myeloid sarcoma: Interestingly, in a previous study, we found that adiponectin levels in both serum and cerebrospinal fluid (CSF) are increased in MS patients compared to healthy controls and significantly correlated with higher activity of the disease and worse prognosis, suggesting a pivotal role of adiponectin in MS immune responses [20].